The Fort Worth Press - Florence Connects 65,000+ Study Sites and 600+ Sponsors Worldwide - Unleashing the Next Era of Clinical Trial Intelligence

USD -
AED 3.672504
AFN 65.503991
ALL 80.193613
AMD 365.443623
ANG 1.789783
AOA 918.000367
ARS 1475.150612
AUD 1.415829
AWG 1.80125
AZN 1.70397
BAM 1.690479
BBD 2.011669
BDT 122.606854
BGN 1.696366
BHD 0.37668
BIF 2985.954449
BMD 1
BND 1.277583
BOB 11.640953
BRL 5.222404
BSD 0.998833
BTN 95.261679
BWP 13.45607
BYN 3.037988
BYR 19600
BZD 2.008816
CAD 1.38765
CDF 2273.000362
CHF 0.813662
CLF 0.023213
CLP 913.600415
CNY 6.743204
CNH 6.74452
COP 3115.519253
CRC 449.371191
CUC 1
CUP 26.5
CVE 95.306625
CZK 20.930304
DJF 177.864212
DKK 6.460604
DOP 58.464065
DZD 131.663425
EGP 49.854358
ERN 15
ETB 161.573793
EUR 0.864504
FJD 2.234204
FKP 0.739036
GBP 0.73929
GEL 2.610391
GGP 0.739036
GHS 10.937378
GIP 0.739036
GMD 73.503851
GNF 8773.931458
GTQ 7.6209
GYD 208.928649
HKD 7.84715
HNL 26.775574
HRK 6.512304
HTG 130.645231
HUF 313.830388
IDR 17828.1
ILS 2.955104
IMP 0.739036
INR 95.450504
IQD 1308.440296
IRR 1374587.503816
ISK 122.903814
JEP 0.739036
JMD 158.174511
JOD 0.70904
JPY 159.30404
KES 129.09806
KGS 87.450384
KHR 4041.661265
KMF 427.00035
KPW 900.000294
KRW 1416.470383
KWD 0.30868
KYD 0.832361
KZT 463.468603
LAK 22542.892951
LBP 89443.536886
LKR 332.365271
LRD 181.287005
LSL 16.158607
LTL 2.95274
LVL 0.60489
LYD 6.359825
MAD 9.264013
MDL 17.319677
MGA 4300.099399
MKD 53.178616
MMK 2099.791609
MNT 3596.010349
MOP 8.073123
MRU 40.112364
MUR 47.103741
MVR 15.450378
MWK 1731.967674
MXN 17.023504
MYR 4.085904
MZN 63.910377
NAD 16.158607
NGN 1359.570377
NIO 36.760448
NOK 9.442604
NPR 152.41886
NZD 1.677149
OMR 0.381252
PAB 0.998833
PEN 3.368858
PGK 4.486797
PHP 61.465038
PKR 277.41994
PLN 3.72275
PYG 5995.073253
QAR 3.641125
RON 4.526704
RSD 101.421842
RUB 83.996716
RWF 1468.77566
SAR 3.752773
SBD 8.048583
SCR 13.755996
SDG 600.503676
SEK 9.527038
SGD 1.279604
SHP 0.740866
SLE 24.503667
SLL 20969.499227
SOS 570.811185
SRD 37.974504
STD 20697.981008
STN 21.176369
SVC 8.739358
SYP 13001.999906
SZL 16.156273
THB 33.143038
TJS 9.223994
TMT 3.51
TND 2.928476
TOP 2.40776
TRY 47.867504
TTD 6.76693
TWD 32.021604
TZS 2646.873244
UAH 44.681879
UGX 3710.618436
UYU 40.019016
UZS 11890.747223
VES 770.109104
VND 26148.5
VUV 117.940389
WST 2.73449
XAF 566.970915
XAG 0.015456
XAU 0.000229
XCD 2.70255
XCG 1.800078
XDR 0.707052
XOF 566.970915
XPF 103.081378
YER 237.203589
ZAR 16.16923
ZMK 9001.203584
ZMW 18.87722
ZWL 321.999592
  • CMSC

    -0.0250

    21.45

    -0.12%

  • BCC

    -0.8900

    83.24

    -1.07%

  • RBGPF

    0.0000

    71.34

    0%

  • BTI

    -0.2900

    57.06

    -0.51%

  • NGG

    -0.1500

    81.05

    -0.19%

  • RYCEF

    0.1300

    20.84

    +0.62%

  • BP

    0.2196

    42.53

    +0.52%

  • GSK

    -0.4785

    49.52

    -0.97%

  • BCE

    0.1500

    23.47

    +0.64%

  • RIO

    -0.4100

    95.68

    -0.43%

  • CMSD

    -0.0100

    21.58

    -0.05%

  • JRI

    0.0635

    12.61

    +0.5%

  • RELX

    -0.2400

    34.43

    -0.7%

  • VOD

    0.2000

    16.42

    +1.22%

  • AZN

    -0.7900

    156.45

    -0.5%

Florence Connects 65,000+ Study Sites and 600+ Sponsors Worldwide - Unleashing the Next Era of Clinical Trial Intelligence
Florence Connects 65,000+ Study Sites and 600+ Sponsors Worldwide - Unleashing the Next Era of Clinical Trial Intelligence

Florence Connects 65,000+ Study Sites and 600+ Sponsors Worldwide - Unleashing the Next Era of Clinical Trial Intelligence

With the industry's largest network of sites, Florence sets a new benchmark for AI-enabled study startup, workflow automation, and operational risk management.

Text size:

ATLANTA, GA / ACCESS Newswire / October 23, 2025 / Florence Healthcare reinforced its position as the global leader in clinical trial operations with a major milestone: Florence Trial Operations Platform now connects 65,000 study sites spanning more than 600 sponsors across 90+ countries, forming the industry's largest network. Recognized as the #1 clinical trial technology for six consecutive years, Florence continues to set the standard for startup speed, workflow automation, and operational risk management across sponsor study portfolios.

"Florence was built to bring sponsors and sites into a shared operational space," said Ryan Jones, CEO of Florence Healthcare. "First, we fully digitized startup to eliminate manual bottlenecks and paper workflows. Now, we're using AI to enhance speed and augment intelligence across 65,000 study sites globally - arming sponsors with portfolio-wide operational visibility so they can anticipate trial risk, act on insights, and drive execution on the ground."

Solving the $1 million per study problem

While digital-first sites set new standards for operational speed and efficiency, much of the industry still remains offline. Only 30% of global sites currently use an eISF, leaving roughly 200,000 sites dependent on inefficient paper processes for study startup, document collection and storage, regulatory process management, monitoring and closeout.

This lack of digitization costs sponsors an estimated $1 million per study in lost productivity, rework, quality and compliance risk.

Florence is closing this digital divide through the fastest growing clinical research network of 65,000 study sites and 600+ sponsors. By digitizing 100% of operational workflows, Florence sets the standard for startup speed, operational cost reduction, and risk control.

The results are compelling:

  • Up to 70% faster last mile study startup operations compared to the average site startup time for a Top 10 global pharmaceutical sponsor.

  • $141M annual operational cost takeout by automating site readiness workflows, based on active daily users and total hours saved per year across Florence's study site network.

  • 51% increase in eTMF QA pass rates from 65% to 98.7%, due to built-in operational audits and automated compliance checks to control risk.

Shaping the Future of Study Operations

Florence is embedding AI across the study lifecycle to unlock operational data intelligence, recommend next-best actions, strengthen risk control, and improve operating efficiency.

Site Identification & Feasibility

Drawing on the industry's largest network of site intelligence, Florence enables sponsors and CROs to identify the most qualified sites by therapeutic area, geography, and performance, while AI-assisted feasibility surveys ensure faster, more accurate completion.

Study Startup

AI-enabled contracting and document exchange between eTMF and eISF automates SSU document exchange, while generative AI redlining shortens contract review cycles, compares terms in seconds, and dramatically reduces time to activation.

Remote Monitoring

AI-powered reporting surfaces early risk signals from operational audit trails and site data, providing real-time visibility and enabling proactive intervention. These insights minimize the need for on-site visits and ensure trials stay on schedule.

Together, these advancements move sponsors and CROs from manual oversight to intelligent execution across global study portfolios. Through its open API network, Florence rapidly integrates and extends its trial operation capabilities to other eClinical partner systems.

Florence AI operates at the speed of trust, ensuring every study remains fully aligned with FDA, EMA, HIPAA, GDPR, EU Annex 11, ICH E6 (R3), and GCP standards.

All capabilities will be available in December 2025.

Join the Movement: Research Revolution 2025

Florence will showcase its newest capabilities at Research Revolution 2025, the company's annual global event (October 26-28, 2025) bringing together sponsors, CROs, and research sites. Be part of the global revolution. Watch it live at: https://researchrevolutionsummit.com/live/

About Florence Healthcare

Florence is a purpose-built platform that connects sponsors and sites to accelerate clinical trials, improve operational capacity, and reduce risk. Designed for scale, Florence streamlines workflows, enhances collaboration, and delivers real-time visibility across studies-empowering research teams to move faster, stay inspection-ready, and increase trial throughput with fewer resources.

Contact Information

Seema Sheth-Voss
[email protected]
(888) 829-0896

SOURCE: Florence Healthcare



View the original press release on ACCESS Newswire

L.Davila--TFWP